UK Markets open in 1 hr 53 mins

DBV Technologies S.A. (DBVTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
4.16000.0000 (0.00%)
At close: 12:12PM EST
Full screen
Trade prices are not sourced from all markets
Previous close4.1600
Open4.1600
Bid0.0000 x 0
Ask0.0000 x 0
Day's range4.1600 - 4.1600
52-week range3.9750 - 19.0100
Volume8,138
Avg. volume0
Market cap136.549M
Beta (5Y monthly)2.22
PE ratio (TTM)N/A
EPS (TTM)-2.6990
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2021

    Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights09/30/202155,011,687 Total gross of voting rights: 55,011,687 Total net* of voting rights: 54,936,287 * Total net = total number of voting rights attached to shares – shares w

  • Globe Newswire

    Monthly information regarding the total number of voting rights and total number of shares of the Company as of August 31, 2021

    Monthly information regarding the total number of voting rights and total number of shares of the Company as of August 31, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights08/31/202155,011,687 Total gross of voting rights: 55,011,687 Total net* of voting rights: 54,963,687 * Total net = total number of voting rights attached to shares – shares with

  • Globe Newswire

    DBV Technologies to Participate at Upcoming Investor Conferences

    Montrouge, France, August 31, 2021 DBV Technologies to Participate at Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that DBV Technologies’ senior management team will participate in upcoming virtual investor conferences in September. Goldman Sachs Eleventh Annual Biotech Symposium Company management will participate in virtual investor meetings on September 7, 2021. Citi